There is an increasing interest among men in cosmetic procedures, but to date, there is little research in this area to guide physicians. In fact, one analysis shows that of 17 clinical trials on botulinum toxins for aesthetic indications, only 11 percent of the patients were men.
This is noteworthy because men and women have faces that are structurally different and as such, they may respond differently to botulinum toxin injections, says Derek Jones, M.D., of Skin Care and Laser Physicians, Beverly Hills. Dr. Jones is the lead author of an analysis of Xeomin treatment for glabellar frown lines in men.
>>Read More from Dermatology Times